Emcure Pharmaceuticals Ltd.
EMCURE
Rangering i aksjer
#4306
Emcure Pharmaceuticals Limited is committed to providing high-quality,... Emcure Pharmaceuticals Limited is committed to providing high-quality, cost-effective healthcare solutions to a global market. The company boasts a diverse product lineup spanning numerous medical fields, such as women's health (gynecology), anti-infectives, pain relief, nutritional supplements (vitamins, minerals, and nutrients), hematology, oncology, respiratory treatments, HIV antivirals, gastrointestinal remedies, anti-diabetics, neurological medications, and cardiovascular therapies. Notable brand names under their umbrella include Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym. Founded in 1981, Emcure Pharmaceuticals Limited is headquartered in Pune, India.
Aksjekurs
$19.06
Markedsverdi
$3.62B
Endring (1 dag)
-1.83%
Endring (1 år)
20.50%
Land
IN
Handel Emcure Pharmaceuticals Ltd. (EMCURE)
Kategori
Healthcare
Historikk for aksjesplitt for Emcure Pharmaceuticals Ltd. (EMCURE)
Aksjen Emcure Pharmaceuticals Ltd. (symbol: EMCURE) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én EMCURE-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 EMCURE-aksjer.
Den nyeste splittelsen skjedde Oct 22, 2026.
Én EMCURE-aksje kjøpt før Oct 22, 2026 tilsvarer i dag 0 EMCURE-aksjer.
Liste over aksjesplitt
| År | Splitt | Multiplikator | Kumulativ multiplikator |
|---|---|---|---|
| Ikke nok data for de angitte datoene. | |||
Aksjesplitt for lignende selskaper eller konkurrenter
| Selskap | Antall aksjesplitt | Kumulativ multiplikator | Land |
|---|---|---|---|
| 0 | - |
DE
|
|
| 0 | - |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
